C392 Pill - pink capsule/oblong, 14mm
Pill with imprint C392 is Pink, Capsule/Oblong and has been identified as Deferasirox 180 mg. It is supplied by Cipla USA, Inc.
Deferasirox is used in the treatment of Iron Overload; Thalassemia; Hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C392
Deferasirox
- Imprint
- C392
- Strength
- 180 mg
- Color
- Pink
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Chelating agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- National Drug Code (NDC)
- 69097-0392
Related images for "C392"
More about deferasirox
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: chelating agents
- Breastfeeding
- En español
Patient resources
- Deferasirox drug information
- Deferasirox (Advanced Reading)
- Deferasirox Tablets
- Deferasirox Tablets For Oral Suspension
Other brands
Jadenu, Exjade, Jadenu Sprinkle
Professional resources
- Deferasirox monograph
- Deferasirox (FDA)
- Deferasirox Tablets (FDA)
- Deferasirox Tablets for Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.